Fixing innovation policy: A structural perspective

SM Benjamin, AK Rai - Geo. Wash. L. Rev., 2008 - HeinOnline
Both theory and empirics support the primacy of technological innovation in securing long-
term economic growth and, ultimately, human welfare.'Innovation will also be central to …

Innovation Incentives or Corrupt Conflicts of Interest: Moving beyond Jekyll and Hyde in Regulating Biomedical Academic-Industry Relationships

PL Taylor - Yale J. Health Pol'y L. & Ethics, 2013 - HeinOnline
The most contentious, unresolved issue in biomedicine in the last twentyfive years has been
how to best address compensated partnerships between academic researchers and the …

Pharmacogenomics: Tailoring the Drug Approval Process for Designer Drugs

M Crews - J. Contemp. Health L. & Pol'y, 2007 - HeinOnline
Pharmacogenomics is the practice of tailoring drugs to particular genetic profiles, with the
ambition of reducing instances of adverse reactions and ensuring optimal treatment.'1 0 …

Principles over Principals: How Innovation Affects the Agency Relationship in Medical and Legal Practice

JJZ Polaris - Yale J. Health Pol'y L. & Ethics, 2014 - HeinOnline
This Note outlines a conceptual framework for defining and analyzing innovation in the
professional practice of medicine and law. The two professions have structural and historical …

Advisory Commitees at FDA: The Hinchey Amendment and'Conflict of Interest'Waivers

E Lietzan - Journal of Health Law, 2006 - papers.ssrn.com
Congress was in 2006 considering an amendment that would prevent the agency from using
appropriated funds to waive certain conflicts of interest identified by members of its advisory …

Συγκριτική ανάλυση μεταξύ FDA και EMA

Α Μπαρτζώκα - 2022 - search.proquest.com
Ο Ευρωπαϊκός Οργανισμός Φαρμάκων (ΕΜΑ) και ο FDA έχουν κοινούς στόχους, μεταξύ των
οποίων η προστασία της δημόσιας υγείας, η αξιολόγηση της ασφάλειας και της …

Prescription for a Cure: Does the FDA's Draft Guidance Adequately Manage Advisory Committee Members' Conflicts of Interest

IJ Kellogg - Stan. L. & Pol'y Rev., 2008 - HeinOnline
On November 16, 1999, the Gastrointestinal Drugs Advisory Committee of the Food and
Drug Administration (FDA) recommended prompt approval of the drug Lotronex, used to …

Risky Business: The FDA Bans Ephedra, and Gets a Leg Up on the Dietary Supplement Industry

M Davenport - Geo. JL & Pub. Pol'y, 2007 - HeinOnline
The relationship between science and politics is a complicated one, and one that affects
policymaking and the safety and health of American citizens in numerous arenas. Alternative …